Akira Harada

750 total citations
42 papers, 495 citations indexed

About

Akira Harada is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Akira Harada has authored 42 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Akira Harada's work include Fungal Biology and Applications (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Thyroid Disorders and Treatments (4 papers). Akira Harada is often cited by papers focused on Fungal Biology and Applications (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Thyroid Disorders and Treatments (4 papers). Akira Harada collaborates with scholars based in Japan, United States and China. Akira Harada's co-authors include Jerome M. Hershman, Shigetoshi Takahashi, ALLAN W. REED, William J. Dignam, Stanley Friedman, Glenn D. Braunstein, A. EUGENE PEKARY, Christine Derzko, Raphael Jewelewicz and Akira Ando and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Endocrinology and Organometallics.

In The Last Decade

Akira Harada

39 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akira Harada Japan 14 149 95 57 49 47 42 495
Kyuyoun Ahn South Korea 15 123 0.8× 248 2.6× 37 0.6× 24 0.5× 81 1.7× 28 699
Edwin Rowold United States 14 143 1.0× 168 1.8× 71 1.2× 28 0.6× 20 0.4× 23 622
M. Schleyer Germany 12 76 0.5× 121 1.3× 42 0.7× 29 0.6× 30 0.6× 51 530
Betty Lawrence United States 9 225 1.5× 138 1.5× 12 0.2× 30 0.6× 45 1.0× 15 529
Kelly S. Persons United States 17 107 0.7× 173 1.8× 25 0.4× 20 0.4× 28 0.6× 28 830
Jeanne Stadler France 9 35 0.2× 156 1.6× 45 0.8× 56 1.1× 27 0.6× 17 487
Kyung Won Chung United States 12 121 0.8× 116 1.2× 80 1.4× 17 0.3× 20 0.4× 39 484
Margaret C. Stuart Australia 14 202 1.4× 321 3.4× 35 0.6× 72 1.5× 69 1.5× 22 821
D Vandekerckhove Belgium 20 128 0.9× 252 2.7× 66 1.2× 85 1.7× 34 0.7× 70 1000
Yaping Shen China 15 44 0.3× 202 2.1× 39 0.7× 25 0.5× 41 0.9× 36 503

Countries citing papers authored by Akira Harada

Since Specialization
Citations

This map shows the geographic impact of Akira Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Harada more than expected).

Fields of papers citing papers by Akira Harada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akira Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Harada. The network helps show where Akira Harada may publish in the future.

Co-authorship network of co-authors of Akira Harada

This figure shows the co-authorship network connecting the top 25 collaborators of Akira Harada. A scholar is included among the top collaborators of Akira Harada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akira Harada. Akira Harada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torisu, Takehiro, Akira Harada, Yoshiaki Taniguchi, et al.. (2023). Usefulness of Serum Leucine-Rich Alpha-2 Glycoprotein as a Surrogate Marker of Small Bowel Mucosal Injury in Crohn’s Disease. Inflammatory Intestinal Diseases. 8(2). 69–76. 4 indexed citations
2.
Harada, Akira, Takehiro Torisu, Shin Fujioka, et al.. (2021). Risk of Rebleeding in Patients with Small Bowel Vascular Lesions. Internal Medicine. 60(23). 3663–3669. 2 indexed citations
3.
Harada, Akira, Koichi Kurahara, Tomohiko Moriyama, et al.. (2019). Risk factors for reflux esophagitis after eradication of Helicobacter pylori. Scandinavian Journal of Gastroenterology. 54(10). 1183–1188. 3 indexed citations
4.
Harada, Akira, Takehiro Torisu, Yasuharu Okamoto, et al.. (2019). Predictive Factors for Rebleeding after Negative Capsule Endoscopy among Patients with Overt Obscure Gastrointestinal Bleeding. Digestion. 101(2). 129–136. 5 indexed citations
5.
Kurahara, Koichi, et al.. (2016). Whipple's disease diagnosed using electron microscopy and polymerase chain reaction.. PubMed. 113(11). 1894–1900. 3 indexed citations
6.
Shibuya, Tomoyoshi, Toshifumi� Ohkusa, Tetsuji Yokoyama, et al.. (2009). Colonic mucosal lesions associated with long‐term or short‐term administration of nonsteroidal anti‐inflammatory drugs. Colorectal Disease. 12(11). 1113–1121. 6 indexed citations
7.
Takayama, Koichi, Lína Zhang, Junji Uchino, et al.. (2009). Tetracycline-inducible promoter-based conditionally replicative adenoviruses for the control of viral replication. Cancer Gene Therapy. 16(5). 415–422. 3 indexed citations
8.
Harada, Akira, Toshifumi� Ohkusa, Mitsuo Sakamoto, et al.. (2008). Identification of bacteria from blood in febrile patients with ulcerative colitis by terminal restriction fragment length polymorphism profile analysis of 16S rRNA gene. Scandinavian Journal of Gastroenterology. 43(4). 423–430. 3 indexed citations
9.
Uchino, Junji, Koichi Takayama, Akira Harada, et al.. (2007). Tumor targeting carboxylesterase fused with anti-CEA scFv improve the anticancer effect with a less toxic dose of irinotecan. Cancer Gene Therapy. 15(2). 94–100. 18 indexed citations
10.
Takayama, Koichi, Junji Uchino, Akira Harada, et al.. (2006). Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-β type II receptor gene. Cancer Gene Therapy. 13(9). 864–872. 29 indexed citations
11.
Ochi, Kazuhide, et al.. (2003). Changes in serum macrophage-related factors in patients with chronic inflammatory demyelinating polyneuropathy caused by intravenous immunoglobulin therapy. Journal of the Neurological Sciences. 208(1-2). 43–50. 15 indexed citations
12.
Harada, Akira, et al.. (2002). Dendritic Antibody Supramolecules: Combination of IgM and IgG. Chemistry Letters. 32(1). 18–19. 6 indexed citations
13.
Yasunaga, Yuji, et al.. (2001). Femoral head dysplasia in Morquio disease type A: Bilateral varus osteotomy of the femur. Acta Orthopaedica Scandinavica. 72(1). 18–21. 25 indexed citations
14.
Ando, Akira, Akira Harada, Kiyoshi Miura, & Yutaka Tamai. (2001). A gene encoding a hydrophobin, fvh1, is specifically expressed after the induction of fruiting in the edible mushroom Flammulina velutipes. Current Genetics. 39(3). 190–197. 35 indexed citations
15.
Yasunaga, Yuji, et al.. (1999). Rotational acetabular osteotomy for advanced osteoarthrosis secondary to dysplasia of the hip. Archives of Orthopaedic and Trauma Surgery. 119(5-6). 253–257. 16 indexed citations
16.
Harada, Akira. (1996). An Overview on Development of Functionalized Antibodies.. KAGAKU TO SEIBUTSU. 34(8). 522–527. 1 indexed citations
17.
Almeida, A. M. R., et al.. (1994). Epidemiological studies on soybean mosaic virus in Brazil. Fitopatologia Brasileira. 19(3). 401–407. 2 indexed citations
18.
Ashitaka, Y, et al.. (1981). Effects of surgical treatment and chemotherapy upon choriocarcinoma and its clinical courses. 16(4). 704–712.
19.
Harada, Akira, Jerome M. Hershman, ALLAN W. REED, et al.. (1979). Comparison of Thyroid Stimulators and Thyroid Hormone Concentrations in the Sera of Pregnant Women*. The Journal of Clinical Endocrinology & Metabolism. 48(5). 793–797. 95 indexed citations
20.
Harada, Akira, et al.. (1961). A Study of Benzol Poisoning in an Animal-model Factory. Sangyo Igaku. 3(3). 205–206. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyuyoun Ahn Breakdown of academic impact, for papers by Edwin Rowold Breakdown of academic impact, for papers by M. Schleyer Breakdown of academic impact, for papers by Betty Lawrence Breakdown of academic impact, for papers by Kelly S. Persons Breakdown of academic impact, for papers by Jeanne Stadler Breakdown of academic impact, for papers by Kyung Won Chung Breakdown of academic impact, for papers by Margaret C. Stuart Breakdown of academic impact, for papers by D Vandekerckhove Breakdown of academic impact, for papers by Yaping Shen
Rankless by CCL
2026